TREATMENT OF ANXIETY NEUROSES AND PSYCHOSOMATIC SYNDROMES USING A NEW LIBRIUM-METABOLITE, RO 4-5360.
D000293:Adolescent; D000928:Antidepressive Agents; D001007:Anxiety; D001008:Anxiety Disorders; D001247:Asthenia; D002707:Chlordiazepoxide; D005853:Geriatrics; D006801:Humans; D009497:Neurotic Disorders; D009771:Obsessive-Compulsive Disorder; D011611:Psychosomatic Medicine; D007319:Sleep Initiation and Maintenance Disorders; D013577:Syndrome
D000928:Antidepressive Agents; D002707:Chlordiazepoxide
ADOLESCENCE; ANTIDEPRESSIVE AGENTS; ASTHENIA; CHLORDIAZEPOXIDE; GERIATRICS; INSOMNIA; NEUROSES, ANXIETY; NEUROSES, OBSESSIVE COMPULSIVE; PSYCHOSOMATIC MEDICINE